Subscribe to our Newsletters !!
Although copying the blueprint is extremely comple
Eppendorf introduces a new addition to their Eppen
The recent rabies death of an 11 year old Canadian
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
Generic medicines have become a cornerstone in hea
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to the latest issue of Micro
Researchers in the US have found a potential therapeutic treatment for SARS-CoV-2, the virus which causes COVID-19, along with other coronaviruses. Pathogenic coronaviruses are a major threat to international public health, as shown by the SARS-CoV, MERS-CoV, along with the recently emerged SARS-CoV-2.
All these coronavirus 3C-like proteases, called 3CLpro, are strong therapeutic targets because they play vital roles in coronavirus replication, ” the researchers stated.
“Vaccine developments and treatments are the biggest targets in COVID-19 research, and therapy is actually key,” explained Kyeong-Ok Chang, a professor at Kansas State University in the US.
“This paper clarifies protease inhibitors targeting coronavirus 3CLpro, that can be a well-known therapeutic goal,” Chang explained.
These findings imply that this series of chemicals should be researched further as a potential therapeutic for human coronavirus infection, they said.
